𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resistance profile of entecavir in patients with chronic hepatitis B

✍ Scribed by T. Santantonio; M. Fasano

Book ID
118648874
Publisher
Elsevier
Year
2008
Tongue
English
Weight
249 KB
Volume
2
Category
Article
ISSN
1594-5804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Entecavir resistance is rare in nucleosi
Entecavir resistance is rare in nucleoside naΓ―ve patients with hepatitis B
✍ Richard J. Colonno; Ronald Rose; Carl J. Baldick; Steven Levine; Kevin Pokornows πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 378 KB

a HBV DNA Ο½7 Ο« 10 5 copies/mL by bDNA assay Ο© loss of HBeAg (Study AI463022) or normalization of ALT (Study AI463027). b HBV DNA Ο½7 Ο« 10 5 copies/mL by bDNA assay. c HBV DNA Υ†7 Ο« 10 5 copies/mL by bDNA assay.

Adefovir-based combination therapy with
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B
✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV ΓΎ LAM therapy